Grifols, S.A. acquired 51% stake in Medcom Advance from Medcomtech, S.A. for €9.7 million.
February 24, 2019
Share
Grifols, S.A. (BME:GRF) acquired 51% stake in Medcom Advance from Medcomtech, S.A. (BME:MED) for €9.7 million on February 25, 2019. Uría Menéndez Abogados, S.L.P. acted as legal advisor to Medcom Advance. Degroof Petercam and Osborne Clarke also acted as advisors in the transaction.
Grifols, S.A. (BME:GRF) completed the acquisition of 51% stake in Medcom Advance from Medcomtech, S.A. (BME:MED) on February 25, 2019.
Medcom Tech SA is a Spain-based company primarily engaged in the distribution and wholesale of technologically advanced products in the areas of Orthopedics, Biologicals, Traumatology and Neurosurgery in Spain, Portugal and Italy. The Company comprises of four departments: Department of Goods, Department of medical professionals, Department of Administration and Logistics and Department of Finance. The product range offered by the Company includes devices treating spine disorders (Dervical, Dorsal of Lumbar pathologies), thousands of patented prosthetic implants for surgery, implants used to synthesize fractures, prosthetic implants for upper limb and foot, as well as medical instruments and precision accessories, among others. The Company also has a license to distribute the patents of such companies as United Ortopedic Corporation, K2M, Bone Support, PAN Medical Ltd, Ranier Technology Ltd, Ascencion Orthopedics and Extremity Medical LLC, among others.
MEDCOMTECH, S.A. 
